Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 78.20
-7.70 (-8.96%)
At close: Oct 8, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 8.39 billion as of October 9, 2026. It is the 19,277th most valuable company in the world and the 827th biggest in Taiwan.
Market Cap
8.39B
Enterprise Value
8.12B
Revenue
n/a
Global Rank
Country Rank
#827 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has increased from 4.62B to 8.39B, an increase of 81.53%. That is a compound annual growth rate of 98.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 8.39B | 101.08% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 58.37B |
| A-Top Health Biotech | 37.18B |
| HanchorBio | 23.17B |
| Elixiron Immunotherapeutics (Cayman) Limited | 20.88B |
| Intelligene | 7.92B |
| Uwell Biopharma | 5.64B |
| Tripartite Therapeutics | 5.07B |
| BIONET Therapeutics | 2.60B |